|
1
|
Hoffman JI and Kaplan S: The incidence of
congenital heart disease. J Am Coll Cardiol. 39:1890–1900. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Srivastava D: Making or breaking the
heart: From lineage determination to morphogenesis. Cell.
126:1037–1048. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Somerville J: Grown-up congenital heart
disease - medical demands look back, look forward 2000. Thorac
Cardiovasc Surg. 49:21–26. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van der Linde D, Konings EE, Slager MA,
Witsenburg M, Helbing WA, Takkenberg JJ and Roos-Hesselink JW:
Birth prevalence of congenital heart disease worldwide: A
systematic review and meta-analysis. J Am Coll Cardiol.
58:2241–2247. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garside VC, Chang AC, Karsan A and
Hoodless PA: Co-ordinating Notch, BMP, and TGF-β signaling during
heart valve development. Cell Mol Life Sci. 70:2899–2917. 2013.
View Article : Google Scholar
|
|
6
|
High FA and Epstein JA: The multifaceted
role of Notch in cardiac development and disease. Nat Rev Genet.
9:49–61. 2008. View
Article : Google Scholar
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gangaraju VK and Lin H: MicroRNAs: Key
regulators of stem cells. Nat Rev Mol Cell Biol. 10:116–125. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng Y and Yu X: Cardinal roles of miRNA
in cardiac development and disease. Sci China Life Sci.
54:1113–1120. 2011. View Article : Google Scholar
|
|
12
|
Thum T, Catalucci D and Bauersachs J:
MicroRNAs: Novel regulators in cardiac development and disease.
Cardiovasc Res. 79:562–570. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kasinski AL and Slack FJ: Epigenetics and
genetics MicroRNAs en route to the clinic: Progress in validating
and targeting microRNAs for cancer therapy. Nat Rev Cancer.
11:849–864. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Callegari E, Gramantieri L, Domenicali M,
D'Abundo L, Sabbioni S and Negrini M: MicroRNAs in liver cancer: A
model for investigating pathogenesis and novel therapeutic
approaches. Cell Death Differ. 22:46–57. 2015. View Article : Google Scholar
|
|
15
|
Zhu S, Cao L, Zhu J, Kong L, Jin J, Qian
L, Zhu C, Hu X, Li M and Guo X: et al Identification of maternal
serum microRNAs as novel non-invasive biomarkers for prenatal
detection of fetal congenital heart defects. Clin Chim Acta.
424:66–72. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu Z, Han S, Hu P, Zhu C, Wang X, Qian L
and Guo X: Potential role of maternal serum microRNAs as a
biomarker for fetal congenital heart defects. Med Hypotheses.
76:424–426. 2011. View Article : Google Scholar
|
|
17
|
Andersson ER, Sandberg R and Lendahl U:
Notch signaling: Simplicity in design, versatility in function.
Development. 138:3593–3612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kopan R and Ilagan MXG: The canonical
Notch signaling pathway: Unfolding the activation mechanism. Cell.
137:216–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iso T, Kedes L and Hamamori Y: HES and
HERP families: Multiple effectors of the Notch signaling pathway. J
Cell Physiol. 194:237–255. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang ACY, Fu Y, Garside VC, Niessen K,
Chang L, Fuller M, Setiadi A, Smrz J, Kyle A and Minchinton A: et
al Notch initiates the endothelial-to-mesenchymal transition in the
atrioventricular canal through autocrine activation of soluble
guanylyl cyclase. Dev Cell. 21:288–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chau MDL, Tuft R, Fogarty K and Bao ZZ:
Notch signaling plays a key role in cardiac cell differentiation.
Mech Dev. 123:626–640. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bishayee K, Ghosh S, Mukherjee A,
Sadhukhan R, Mondal J and Khuda-Bukhsh AR: Quercetin induces
cytochrome-c release and ROS accumulation to promote apoptosis and
arrest the cell cycle in G2/M, in cervical carcinoma: Signal
cascade and drug-DNA interaction. Cell Prolif. 46:153–163. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Verheugt CL, Uiterwaal CS, Grobbee DE and
Mulder BJ: Long-term prognosis of congenital heart defects: A
systematic review. Int J Cardiol. 131:25–32. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zomer AC, Vaartjes I, van der Velde ET, de
Jong HM, Konings TC, Wagenaar LJ, Heesen WF, Eerens F, Baur LH and
Grobbee DE: et al Heart failure admissions in adults with
congenital heart disease; risk factors and prognosis. Int J
Cardiol. 168:2487–2493. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sayed AS, Xia K, Salma U, Yang T and Peng
J: Diagnosis, prognosis and therapeutic role of circulating miRNAs
in cardiovascular diseases. Heart Lung Circ. 23:503–510. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
El Ouaamari A, Baroukh N, Martens GA,
Lebrun P, Pipeleers D and van Obberghen E: miR-375 targets
3′-phosphoinositide-dependent protein kinase-1 and regulates
glucose-induced biological responses in pancreatic beta-cells.
Diabetes. 57:2708–2717. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kloosterman WP, Lagendijk AK, Ketting RF,
Moulton JD and Plasterk RH: Targeted inhibition of miRNA maturation
with morpholinos reveals a role for miR-375 in pancreatic islet
development. PLoS Biol. 5:e2032007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang H, Mishra A, Chintagari NR, Gou D
and Liu L: Micro-RNA-375 inhibits lung surfactant secretion by
altering cytoskeleton reorganization. IUBMB Life. 62:78–83.
2010.
|
|
29
|
Cao L, Kong LP, Yu ZB, Han SP, Bai YF, Zhu
J, Hu X, Zhu C, Zhu S and Guo XR: microRNA expression profiling of
the developing mouse heart. Int J Mol Med. 30:1095–1104.
2012.PubMed/NCBI
|
|
30
|
Adams JM and Cory S: The Bcl-2 protein
family: Arbiters of cell survival. Science. 281:1322–1326. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Golestani Eimani B, Sanati MH, Houshmand
M, Ataei M, Akbarian F and Shakhssalim N: Expression and prognostic
significance of bcl-2 and bax in the progression and clinical
outcome of transitional bladder cell carcinoma. Cell J. 15:356–363.
2014.PubMed/NCBI
|
|
32
|
Oltvai ZN, Milliman CL and Korsmeyer SJ:
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that
accelerates programmed cell death. Cell. 74:609–619. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
van der Heyden MA and Defize LH: Twenty
one years of P19 cells: What an embryonal carcinoma cell line
taught us about cardiomyocyte differentiation. Cardiovasc Res.
58:292–302. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
van der Heyden MA, van Kempen MJ, Tsuji Y,
Rook MB, Jongsma HJ and Opthof T: P19 embryonal carcinoma cells: A
suitable model system for cardiac electrophysiological
differentiation at the molecular and functional level. Cardiovasc
Res. 58:410–422. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qin DN, Qian L, Hu DL, Yu ZB, Han SP, Zhu
C, Wang X and Hu X: Effects of miR-19b overexpression on
proliferation, differentiation, apoptosis and Wnt/β-catenin
signaling pathway in P19 cell model of cardiac differentiation in
vitro. Cell Biochem Biophys. 66:709–722. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhu C, Hu DL, Liu YQ, Zhang QJ, Chen FK,
Kong XQ, Cao KJ, Zhang JS and Qian LM: Fabp3 inhibits proliferation
and promotes apoptosis of embryonic myocardial cells. Cell Biochem
Biophys. 60:259–266. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu S, Hu X, Han S, Yu Z, Peng Y, Zhu J,
Liu X, Qian L, Zhu C and Li M: et al Differential expression
profile of long non-coding RNAs during differentiation of
cardiomyocytes. Int J Med Sci. 11:500–507. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yuan S, Zaidi S and Brueckner M:
Congenital heart disease: Emerging themes linking genetics and
development. Curr Opin Genet Dev. 23:352–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Staudt D and Stainier D: Uncovering the
molecular and cellular mechanisms of heart development using the
zebrafish. Annu Rev Genet. 46:397–418. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Olson EN: Gene regulatory networks in the
evolution and development of the heart. Science. 313:1922–1927.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Penton AL, Leonard LD and Spinner NB:
Notch signaling in human development and disease. Semin Cell Dev
Biol. 23:450–457. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
de la Pompa JL: Notch signaling in cardiac
development and disease. Pediatr Cardiol. 30:643–650. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
McDaniell R, Warthen DM, Sanchez-Lara PA,
Pai A, Krantz ID, Piccoli DA and Spinner NB: NOTCH2 mutations cause
Alagille syndrome, a heterogeneous disorder of the notch signaling
pathway. Am J Hum Genet. 79:169–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kamath BM, Spinner NB, Emerick KM, Chudley
AE, Booth C, Piccoli DA and Krantz ID: Vascular anomalies in
Alagille syndrome: A significant cause of morbidity and mortality.
Circulation. 109:1354–1358. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Garg V, Muth AN, Ransom JF, Schluterman
MK, Barnes R, King IN, Grossfeld PD and Srivastava D: Mutations in
NOTCH1 cause aortic valve disease. Nature. 437:270–274. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhou XL and Liu JC: Role of Notch
signaling in the mammalian heart. Braz J Med Biol Res. 47:1–10.
2014. View Article : Google Scholar :
|
